EGFR and neoplasm: EBV, and more precisely, its oncoproteins, initiate tumor formation by modulating many signaling pathways, such as NF-κB, JAK/STAT, Wnt/β-catenin, PI3k/Akt/mTOR and EGFR/MAPK.